Monument Therapeutics (private company)

United Kingdom
See something wrong or missing? Let us know
Offices:Cambridge
Business model:B2B

Monument Therapeutics is a precision neuroscience British startup spun-out from, and partly owned by Cambridge Cognition

Investors: we tracked 6 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 2.32M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Monument Therapeutics

Name Criteria
Finland FinnAdvance
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom iLoF
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Poland Molecule.one
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Nanolyze
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Exogene
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Spirea
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Mable
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
France Phagos
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain mimark
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom MitoRx Therapeutics
67%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top